Finkelstein J J

Avg. Two Year Performance

(24%) Avg. Purchase Return
(11%) Compound
46% Avg. Sale Return
21% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return11%(29%)(39%)(20%)(24%)
Purchase Success Rate1 of 10 of 10 of 10 of 10 of 1
Average Sale Return1%20%(2%)24%46%
Sale Success Rate1 of 11 of 10 of 11 of 11 of 1
Drugs » Drug Manufacturers - Other

President and CEO, Director:

Holdings: 1.64M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--